Lipocine Announces Presentation of LPCN 1021 Clinical Data at ENDO 2015
February 27, 2015 at 09:00 AM EST
Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company, today announced that data from its ongoing Study of Oral Androgen ...